Technology | Colonoscopy Systems | May 23, 2016

FDA Approves Avantis Medical Systems’ Resposable Third Eye Panoramic Colonoscopy Device

Low-cost, multi-use visualization device now available to endoscopists to enhance quality of colonoscopy procedures

Avantis Medical Systems, Third Eye Panoramic colonoscopy device, endoscopes, FDA, resposable

From left to right: (1) Panoramic device’s left-viewing camera, (2) Colonoscope’s forward-viewing camera, (3) Panoramic device’s right-viewing camera. The adenoma seen in this image was hidden from the colonoscope’s view but was detected with the Third Eye Panoramic.

May 23, 2016 — Avantis Medical Systems Inc. announced that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its Third Eye Panoramic device for use as a resposable product for colonoscopies. Previously cleared as a disposable device, this latest clearance now allows Third Eye Panoramic to be marketed in the United States as a resposable device that can be used multiple times prior to disposal.

Third Eye Panoramic is a wide-view visualization device designed to provide gastroenterologists (GIs) and other endoscopists a better look at areas of the colon where cancers and pre-cancerous polyps may be hidden from the view of a traditional colonoscope alone, such as behind folds.  

According to Avantis, this is the only optical device on the market that can easily be used in conjunction with any commonly used colonoscope to improve visualization.  Physicians can integrate the Third Eye Panoramic within their current practices without the need to invest in expensive infrastructure.

The Third Eye Panoramic device contains two video cameras that are directed laterally from its left and right sides. The device is attached to the tip of the colonoscope at the beginning of the procedure, and can be used during both the insertion and withdrawal phases. The Third Eye Panoramic’s lateral images are displayed on each side of the colonoscope’s forward image, resulting in an ultra-wide-angle view of more than 300 degrees.  This panoramic view reveals areas behind folds and flexures (sharp turns) in the colon.

Based on clinical experience, physicians reported that when using the Third Eye Panoramic they were able to detect pre-cancerous polyps (adenomas) in 44 percent of patients.

“I have used the Third Eye Panoramic in dozens of procedures as part of a feasibility study, and I found that the device is easy to use and doesn’t interfere with the function of the colonoscope,” said Moshe Rubin, M.D., director of gastroenterology, New York-Presbyterian/Queens – Weill Cornell Medical College.  “This device accomplishes the goal of expanding the view without requiring conversion to a new scope platform or sacrificing the high-definition image quality and superior handling characteristics of standard colonoscopes.”

The cleaning and disinfection protocols for this device are similar to the methods used to reprocess colonoscopes between uses.

Following this FDA clearance, the company now plans to launch the product as a multi-use device and is currently evaluating strategic partnerships to drive commercial availability.

For more information:

Related Content

Body Vision Medical Announces Release of LungVision
Technology | Lung Cancer | October 05, 2018
Body Vision Medical, a medical device company specializing in lung cancer diagnostics, announced the launch of its...
Check-Cap Announces Interim Results of European Study of C-Scan System Version 3
News | Colonoscopy Systems | September 04, 2018
Check-Cap Ltd. announced the interim results for its post-CE approval study of the C-Scan system Version 3, an...
American Society for Gastrointestinal Endoscopy and Touch Surgery Pilot Video-Based Endoscopic Simulations
News | Endoscopes | June 11, 2018
During the 2018 Digestive Disease Week (DDW) conference June 2-5 in Washington, D.C., the American Society for...
Olympus and Hitachi Healthcare Americas Introduce Arietta 850
News | Ultrasound Imaging | June 04, 2018
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedu
American Cancer Society Updates Colorectal Cancer Screening Guideline
News | Colonoscopy Systems | May 30, 2018
An updated American Cancer Society guideline says colorectal cancer screening should begin at age 45 for people at...
Body Vision Medical Receives FDA Clearance for LungVision Tool
Technology | Lung Cancer | May 09, 2018
Body Vision Medical received clearance from the U.S. Food and Drug Administration (FDA) to market their LungVision Tool...
El Camino Hospital Performs First U.S. Robotic Lung Cancer Bronchoscopy
News | Oncology Diagnostics | April 25, 2018
The interventional pulmonology team at the Taft Center for Clinical Research at El Camino Hospital in Mountain View,...
News | Endoscopes | April 02, 2018
Results from a recent prospective trial found the Wide Area Transepithelial Sampling with 3D Tissue Analysis (WATS3D)...
Auris Health Unveils FDA-Cleared Monarch Platform for Robotic Bronchoscopy
Technology | Endoscopes | March 26, 2018
March 26, 2018 — Auris Health Inc. announced U.S.